On March 1, 2023, the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) published its first untitled letter of the year to Thomas.
HAUPPAUGE, NY / ACCESSWIRE / July 26, 2022 / Emergent Health Corp. ("Emergent") (OTC PINK:EMGE) announces its pending Acquisition Evolutionary Biologics, Inc., (Evolutionary Biologics), a market leading
PolarityTE (NASDAQ:PTE – Get Rating) and Jasper Therapeutics (NASDAQ:JSPR – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk. Profitability This table compares PolarityTE and Jasper Therapeutics’ net margins, […]
PolarityTE, Inc. (NASDAQ:PTE – Get Rating) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 372,900 shares, a growth of 519.4% from the May 15th total of 60,200 shares. Based on an average trading volume of 343,100 shares, the short-interest ratio is presently […]
Equities research analysts forecast that PolarityTE, Inc. (NASDAQ:PTE – Get Rating) will report $810,000.00 in sales for the current quarter, Zacks reports. Two analysts have issued estimates for PolarityTE’s earnings, with the highest sales estimate coming in at $900,000.00 and the lowest estimate coming in at $730,000.00. PolarityTE reported sales of $2.54 million during the […]